Advertisement

Topics

CAR T-cell therapy shows potential in treating chronic lymphocytic leukemia

06:21 EDT 18 Aug 2017 | SmartBrief

Patients with chronic lymphocytic leukemia previously treated with ibrutinib had an overall response rate of 71% to CD19-spec -More

Original Article: CAR T-cell therapy shows potential in treating chronic lymphocytic leukemia

NEXT ARTICLE

More From BioPortfolio on "CAR T-cell therapy shows potential in treating chronic lymphocytic leukemia"

Advertisement
Quick Search
Advertisement
Advertisement